• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南佛罗里达州大型社区医疗保健系统中确诊 COVID-19 病例的流行病学和结局预测因素。

The Epidemiology and Predictors of Outcomes Among Confirmed COVID-19 Cases in a Large Community Healthcare System in South Florida.

机构信息

Office of Human Research, Memorial Healthcare System, 4411 Sheridan Street, Hollywood, FL, 33021, USA.

Division of Infectious Disease, Memorial Healthcare System, 5647 Hollywood Boulevard, Hollywood, FL, 33021, USA.

出版信息

J Community Health. 2021 Aug;46(4):822-831. doi: 10.1007/s10900-020-00957-y. Epub 2021 Jan 7.

DOI:10.1007/s10900-020-00957-y
PMID:33409769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7787879/
Abstract

The novel coronavirus disease 2019 (COVID-19) continues to be a major public health concern. The aim of this study was to describe the presenting characteristics, epidemiology and predictors of outcomes among confirmed COVID-19 cases seen at a large community healthcare system which serves the epicenter and diverse region of Florida. We conducted a retrospective analysis of individuals with lab-confirmed SARS-CoV-2 infection who were seen, from March 2, 2020 to May 31, 2020, at Memorial Healthcare System in South Florida. Data was extracted from a COVID-19 registry of patients with lab-confirmed SARS-CoV-2 infection. Univariate and backward stepwise multivariate logistic regression models were used to determine predictors of key study outcomes. There were a total of 1692 confirmed COVID-19 patients included in this study. Increasing age was found to be a significant predictor of hospitalization, 30-day readmission and death. Having a temperature of 38 °C or more and increasing comorbidity score were also associated with an increased risk of hospitalization. Significant predictors of ICU admission included having a saturated oxygen level less than 90%, hypertension, dementia, rheumatologic disease, having a respiratory rate greater than 24 breaths per minute. Being of Hispanic ethnicity and immunosuppressant utilization greatly increased the risk of 30-day readmission. Having an oxygen saturation less than 90% and an underlying neurological disorder were associated with an increased likelihood of death. Results show that a patient's demographic, underlying condition and vitals at triage may increase or reduce their risk of hospitalization, ICU admission, 30-day readmission or death.

摘要

2019 年新型冠状病毒病(COVID-19)仍然是一个主要的公共卫生关注点。本研究的目的是描述在一个大型社区医疗保健系统中看到的确诊 COVID-19 病例的临床表现、流行病学和结局预测因素,该系统服务于佛罗里达州的震中和多样化地区。我们对 2020 年 3 月 2 日至 2020 年 5 月 31 日期间在南佛罗里达州纪念医疗保健系统就诊的实验室确诊 SARS-CoV-2 感染个体进行了回顾性分析。数据从 COVID-19 患者实验室确诊 SARS-CoV-2 感染登记处提取。使用单变量和向后逐步多变量逻辑回归模型来确定关键研究结局的预测因素。本研究共纳入 1692 例确诊 COVID-19 患者。研究发现,年龄增长是住院、30 天再入院和死亡的重要预测因素。体温 38°C 或更高以及合并症评分增加与住院风险增加相关。入住 ICU 的显著预测因素包括血氧饱和度低于 90%、高血压、痴呆、风湿性疾病、呼吸频率大于 24 次/分钟。西班牙裔和免疫抑制剂的使用大大增加了 30 天再入院的风险。血氧饱和度低于 90%和潜在的神经障碍与死亡的可能性增加相关。结果表明,患者的人口统计学、潜在疾病和分诊时的生命体征可能会增加或降低其住院、入住 ICU、30 天再入院或死亡的风险。

相似文献

1
The Epidemiology and Predictors of Outcomes Among Confirmed COVID-19 Cases in a Large Community Healthcare System in South Florida.南佛罗里达州大型社区医疗保健系统中确诊 COVID-19 病例的流行病学和结局预测因素。
J Community Health. 2021 Aug;46(4):822-831. doi: 10.1007/s10900-020-00957-y. Epub 2021 Jan 7.
2
Racial and Ethnic Disparities in Rates of COVID-19-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death in the United States From March 2020 to February 2021.2020 年 3 月至 2021 年 2 月期间美国 COVID-19 相关住院率、重症监护病房入院率和住院死亡率的种族和民族差异。
JAMA Netw Open. 2021 Oct 1;4(10):e2130479. doi: 10.1001/jamanetworkopen.2021.30479.
3
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.与美国 COVID-19 患者住院死亡率相关的风险因素。
JAMA Netw Open. 2020 Dec 1;3(12):e2029058. doi: 10.1001/jamanetworkopen.2020.29058.
4
Characteristics in Pediatric Patients with Coronavirus Disease 2019 in Korea.韩国2019冠状病毒病儿科患者的特征。
J Korean Med Sci. 2021 May 24;36(20):e148. doi: 10.3346/jkms.2021.36.e148.
5
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
6
Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England.与儿童同住与新冠病毒感染结局的关联:英格兰 1200 万成年人的 OpenSAFELY 队列研究。
BMJ. 2021 Mar 18;372:n628. doi: 10.1136/bmj.n628.
7
Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.伴有确诊的 2019 冠状病毒病(COVID-19)感染住院患者肾素-血管紧张素-醛固酮系统阻滞剂管理(麦吉尔 RAAS-COVID-19):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Feb 5;22(1):115. doi: 10.1186/s13063-021-05080-4.
8
Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study.血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂与 COVID-19 严重程度的关联:一项多中心前瞻性研究。
J Cardiovasc Pharmacol Ther. 2021 May;26(3):244-252. doi: 10.1177/1074248420976279. Epub 2020 Nov 24.
9
Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂对西方人群 COVID-19 的影响。CARDIOVID 登记处。
Rev Esp Cardiol (Engl Ed). 2021 Feb;74(2):175-182. doi: 10.1016/j.rec.2020.05.018. Epub 2020 Jun 5.
10
COVID-19, Australia: Epidemiology Report 18 (Fortnightly reporting period ending 7 June 2020).澳大利亚2019冠状病毒病:流行病学报告18(截至2020年6月7日的两周报告期)
Commun Dis Intell (2018). 2020 Jun 17;44. doi: 10.33321/cdi.2020.44.52.

引用本文的文献

1
The Impact of Comorbidities among Ethnic Minorities on COVID-19 Severity and Mortality in Canada and the USA: A Scoping Review.加拿大和美国少数族裔合并症对 COVID-19 严重程度和死亡率的影响:一项范围综述。
Infect Dis Rep. 2024 Apr 23;16(3):407-422. doi: 10.3390/idr16030030.
2
The epidemiology and treatment outcomes of COVID-19 patients admitted to an intensive care unit in an Iranian hospital in Neyshabur city.内沙布尔市一家伊朗医院重症监护病房收治的新冠肺炎患者的流行病学情况及治疗结果
Health Sci Rep. 2024 Apr 22;7(4):e2049. doi: 10.1002/hsr2.2049. eCollection 2024 Apr.
3
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors.严重 COVID-19 的风险因素:宿主、病毒和环境因素的综述。
Viruses. 2023 Jan 7;15(1):175. doi: 10.3390/v15010175.
4
Characteristics, Vaccination Status and Outcomes Among Healthy Younger Adults in a Large Public Healthcare System in the South Florida Region.南佛罗里达州大型公立医疗系统中健康年轻成年人的特征、疫苗接种状况和结局。
J Community Health. 2022 Apr;47(2):371-377. doi: 10.1007/s10900-022-01062-y. Epub 2022 Jan 21.
5
Characteristics, risk factors, and outcomes associated with readmission in COVID-19 patients: A systematic review and meta-analysis.与 COVID-19 患者再入院相关的特征、风险因素和结局:系统评价和荟萃分析。
Am J Emerg Med. 2022 Feb;52:166-173. doi: 10.1016/j.ajem.2021.12.012. Epub 2021 Dec 11.
6
Comparison of comorbidities among severe and non-severe COVID-19 patients in Asian versus non-Asian populations: A systematic review and meta-analysis.比较亚洲与非亚洲人群中重症与非重症 COVID-19 患者的合并症:系统评价和荟萃分析。
Nurs Open. 2022 Jan;9(1):733-751. doi: 10.1002/nop2.1126. Epub 2021 Nov 10.
7
Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: A systematic review, meta-analysis and call for action.精神和神经疾病与感染新冠病毒的易感性、疾病严重程度及死亡率风险:一项系统综述、荟萃分析及行动呼吁
EClinicalMedicine. 2021 Oct;40:101111. doi: 10.1016/j.eclinm.2021.101111. Epub 2021 Sep 8.
8
What can the neurological manifestations of COVID-19 tell us: a meta-analysis.新冠病毒感染的神经表现能告诉我们什么:一项荟萃分析。
J Transl Med. 2021 Aug 23;19(1):363. doi: 10.1186/s12967-021-03039-2.
9
Neurological comorbidities and COVID-19-related case fatality: A cohort study.神经合并症与 COVID-19 相关病死率:一项队列研究。
J Neurol Sci. 2021 Sep 15;428:117610. doi: 10.1016/j.jns.2021.117610. Epub 2021 Aug 5.

本文引用的文献

1
Genomic evidence for reinfection with SARS-CoV-2: a case study.基因组证据表明 SARS-CoV-2 再次感染:一项案例研究。
Lancet Infect Dis. 2021 Jan;21(1):52-58. doi: 10.1016/S1473-3099(20)30764-7. Epub 2020 Oct 12.
2
Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection by a Phylogenetically Distinct Strain.一株系统发育上不同的毒株导致的有症状的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)再次感染
Clin Infect Dis. 2021 Jul 15;73(2):354-356. doi: 10.1093/cid/ciaa1330.
3
Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing.2019 年冠状病毒病(COVID-19)通过全基因组测序确认为与严重急性呼吸综合征冠状病毒 2 株系不同的病毒再次感染。
Clin Infect Dis. 2021 Nov 2;73(9):e2946-e2951. doi: 10.1093/cid/ciaa1275.
4
Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes.系统性自身免疫性疾病、抗风湿治疗、COVID-19 感染风险和患者结局。
Rheumatol Int. 2020 Sep;40(9):1353-1360. doi: 10.1007/s00296-020-04629-x. Epub 2020 Jul 11.
5
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.纽约市 5279 例 2019 年冠状病毒病患者住院和重症的相关因素:前瞻性队列研究。
BMJ. 2020 May 22;369:m1966. doi: 10.1136/bmj.m1966.
6
Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study.出院的 2019 年冠状病毒病患者的临床特征和结局:一项前瞻性队列研究。
QJM. 2020 Sep 1;113(9):657-665. doi: 10.1093/qjmed/hcaa178.
7
Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California.加利福尼亚州大型医疗保健系统中 COVID-19 患者的结局差异。
Health Aff (Millwood). 2020 Jul;39(7):1253-1262. doi: 10.1377/hlthaff.2020.00598. Epub 2020 May 21.
8
COVID-19 and Racial/Ethnic Disparities.新冠病毒病与种族/民族差异
JAMA. 2020 Jun 23;323(24):2466-2467. doi: 10.1001/jama.2020.8598.
9
COVID-19: Review of Epidemiology and Potential Treatments Against 2019 Novel Coronavirus.新型冠状病毒肺炎:2019新型冠状病毒的流行病学及潜在治疗方法综述
Discoveries (Craiova). 2020 Apr 26;8(2):e108. doi: 10.15190/d.2020.5.
10
Coronavirus (COVID-19): A Review of Clinical Features, Diagnosis, and Treatment.冠状病毒(COVID-19):临床特征、诊断与治疗综述
Cureus. 2020 Mar 21;12(3):e7355. doi: 10.7759/cureus.7355.